Abstract Concurrent chemoradiotherapy is the main treatment for locally advanced cervical cancer, and the incidence of vaginal injury is inevitable after radiotherapy. However, insufficient attention has been paid to the treatment and prevention of acute radiation-induced vaginal injury. Therefore, the mechanism, treatment and prevention of acute vaginal side effects after radiotherapy in cervical cancer were reviewed in this article, aiming to reduce the incidence of vaginal injury, complete the course of radiotherapy and improve the quality of life.
Corresponding Authors:
Lin Anping, Email: 523498501@qq.com
Cite this article:
Qu Xinyue,Liu Shuhua,Yang Zhu et al. Treatment and prevention of acute radiation-induced vaginal injury in cervical cancer[J]. Chinese Journal of Radiation Oncology, 2023, 32(1): 81-85.
Qu Xinyue,Liu Shuhua,Yang Zhu et al. Treatment and prevention of acute radiation-induced vaginal injury in cervical cancer[J]. Chinese Journal of Radiation Oncology, 2023, 32(1): 81-85.
[1] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. DOI: 10.3322/caac.21492. [2] Arbyn M, Weiderpass E, Bruni L, et al.Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis[J]. Lancet Glob Health, 2020,8(2): e191-e203. DOI: 10.1016/S2214-109X(19)30482-6. [3] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2020[J]. CA Cancer J Clin, 2020,70(1):7-30. DOI: 10.3322/caac.21590. [4] Koh WJ, Abu-Rustum NR, Bean S, et al.Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2019,17(1):64-84. DOI: 10.6004/jnccn.2019.0001. [5] Graziottin A, Gambini D.Anatomy and physiology of genital organs-women[J]. Handb Clin Neurol, 2015,130:39-60. DOI: 10.1016/B978-0-444-63247-0.00004-3. [6] Varytė G, Bartkevičienė D.Pelvic radiation therapy induced vaginal stenosis: a review of current modalities and recent treatment advances[J]. Medicina (Kaunas), 2021,57(4):336. DOI: 10.3390/medicina57040336. [7] Singh M, Alavi A, Wong R, et al.Radiodermatitis: a review of our current understanding[J]. Am J Clin Dermatol, 2016,17(3):277-292. DOI: 10.1007/s40257-016-0186-4. [8] De Ruysscher D, Niedermann G, Burnet NG, et al.Radiotherapy toxicity[J]. Nat Rev Dis Primers, 2019,5(1):13. DOI: 10.1038/s41572-019-0064-5. [9] 王庶红, 滕艳. 比亚芬治疗放射性阴道炎患者临床分析[J].中国实用医药,2016,(2):166-167. DOI: 10.14163/j.cnki.11-5547/r.2016.02.122. Wang SH, Teng Y.Clinical analysis of biafine in the treatment of radiation-induced vaginitis[J]. China Practical Medicine, 2016,(2):166-167. DOI: 10.14163/j.cnki.11-5547/r.2016.02.122. [10] Menêses AG, Reis P, Guerra E, et al.Use of trolamine to prevent and treat acute radiation dermatitis: a systematic review and meta-analysis[J]. Rev Lat Am Enfermagem, 2018,26: e2929. DOI: 10.1590/1518-8345.2035.2929. [11] 张茹梅, 鲁媛媛, 王静, 等. 纳米银凝胶联合乳酸菌阴道胶囊治疗放射性阴道炎的临床分析[J].解放军医药杂志,2018,30(3):91-93. DOI: 10.3969/j.issn.2095-140X.2018.03.024. Zhang RM, Lu YY, Wang J, et al.Clinical analysis of nanometer silver gel combined with lacidophilin vaginal capsules in treatment of radioactive vaginitis[J]. Medical & Pharmaceutical Journal of Chinese People's Liberation Army,2018,30(3):91-93. DOI: 10.3969/j.issn.2095-140X.2018.03.024. [12] Stahl JM, Qian JM, Tien CJ, et al.Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy[J]. Support Care Cancer, 2019,27(4):1425-1433. DOI: 10.1007/s00520-018-4441-5. [13] Law E, Kelvin JF, Thom B, et al.Prospective study of vaginal dilator use adherence and efficacy following radiotherapy[J]. Radiother Oncol, 2015,116(1):149-155. DOI: 10.1016/j.radonc.2015.06.018. [14] Bakker RM, ter Kuile MM, Vermeer WM, et al. Sexual rehabilitation after pelvic radiotherapy and vaginal dilator use: consensus using the Delphi method[J]. Int J Gynecol Cancer, 2014,24(8):1499-1506. DOI: 10.1097/IGC.0000000000000253. [15] Miles T, Johnson N. Vaginal dilator therapy for women receiving pelvic radiotherapy[J]. Cochrane Database Syst Rev, 2014,2014(9):CD007291. DOI: 10.1002/14651858.CD007291.pub3. [16] Tsementzi D, Pena-Gonzalez A, Bai J, et al.Comparison of vaginal microbiota in gynecologic cancer patients pre-and post-radiation therapy and healthy women[J]. Cancer Med, 2020,9(11):3714-3724. DOI: 10.1002/cam4.3027. [17] Bai J, Jhaney I, Daniel G, et al.Pilot study of vaginal microbiome using QIIME 2™ in women with gynecologic cancer before and after radiation therapy[J]. Oncol Nurs Forum, 2019,46(2): E48-E59. DOI: 10.1188/19.ONF.E48-E59. [18] 陈建红, 汪军坚, 方静, 等. 宫颈癌患者近距离放疗局部感染的临床分析[J].中华医院感染学杂志,2015,(10):2373-2375. DOI: 10.11816/cn.ni.2015-150617. Chen JH, Wang JJ, Fang J, et al.Clinical analysis of local infections in cervical cancer patients undergoing brachytherapy[J]. Chinese Journal of Nosocomiology,2015(10):2373-2375. DOI: 10.11816/cn.ni.2015-150617. [19] 陆美秋, 杨欣. 宫颈癌可否采用绝经激素治疗[J].中国实用妇科与产科杂志,2016,32(1):67-71. DOI: 10.7504/fk2015120116. Lu MQ, Yang X.Is menopause hormone therapy suitable for cervical cancer?[J].Chinese Journal of Practical Gynecology and Obstetrics,2016,32(1):67-71. DOI: 10.7504/fk2015120116. [20] Vargiu V, Amar ID, Rosati A, et al.Hormone replacement therapy and cervical cancer: a systematic review of the literature[J]. Climacteric, 2021,24(2):120-127. DOI: 10.1080/13697137.2020.1826426. [21] Naumova I, Castelo-Branco C.Current treatment options for postmenopausal vaginal atrophy[J]. Int J Womens Health, 2018,10:387-395. DOI: 10.2147/IJWH.S158913. [22] 潘子旻, 吕卫国. 绝经激素治疗在宫颈癌术后的应用[J].实用妇产科杂志,2014,30(12):887-888. Pan ZM, Lyu WG.Application of menopausal hormone therapy after cervical cancer surgery[J]. Journal of Practical Obstetrics and Gynecology,2014,30(12):887-888. [23] Liu JH.Selective estrogen receptor modulators (SERMS): keys to understanding their function[J]. Menopause, 2020,27(10):1171-1176. DOI: 10.1097/GME.0000000000001585. [24] De Rosa N, Lavitola G, Giampaolino P, et al.Impact of ospemifene on quality of life and sexual function in young survivors of cervical cancer: a prospective study[J]. Biomed Res Int, 2017,2017:7513610. DOI: 10.1155/2017/7513610. [25] Labrie F, Archer DF, Koltun W, et al.Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause[J]. Menopause, 2018,25(11):1339-1353. DOI: 10.1097/GME.0000000000001238. [26] Burton R.Vaginal health and wellness: vaginal laser therapy[J]. Plast Surg Nurs, 2019,39(3):97-102. DOI: 10.1097/PSN.0000000000000273. [27] Hegedus F, Mathew LM, Schwartz RA.Radiation dermatitis: an overview[J]. Int J Dermatol, 2017,56(9):909-914. DOI: 10.1111/ijd.13371. [28] Dale PS, Tamhankar CP, George D, et al. Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects[J]. Cancer Chemother Pharmacol, 2001,47 Suppl: S29-34. DOI: 10.1007/s002800170006. [29] Cosentino D, Piro F.Hyaluronic acid for treatment of the radiation therapy side effects: a systematic review[J]. Eur Rev Med Pharmacol Sci, 2018,22(21):7562-7572. DOI: 10.26355/eurrev_201811_16298. [30] Wierzbicka A, Mańkowska-Wierzbicka D, Cieślewicz S, et al.Interventions preventing vaginitis, vaginal atrophy after brachytherapy or radiotherapy due to malignant tumors of the female reproductive organs-a systematic review[J]. Int J Environ Res Public Health, 2021,18(8): 3932. DOI: 10.3390/ijerph18083932. [31] Delia P, Sansotta G, Pontoriero A, et al.Clinical evaluation of low-molecular-weight hyaluronic acid-based treatment on onset of acute side effects in women receiving adjuvant radiotherapy after cervical surgery: a randomized clinical trial[J]. Oncol Res Treat, 2019,42(4):217-223. DOI: 10.1159/000496036. [32] Galuppi A, Perrone AM, La Macchia M, et al.Local α-tocopherol for acute and short-term vaginal toxicity prevention in patients treated with radiotherapy for gynecologic tumors[J]. Int J Gynecol Cancer, 2011,21(9):1708-1711. DOI: 10.1097/IGC.0b013e318223659d. [33] 王沥浩, 王文慧, 郭咏昕, 等. 胶原蛋白功能概述[J].黑龙江农业科学,2014(3):150-156. DOI: 10.3969/j.issn.1002-2767.2014.03.045. Wang LH, Wang WH, Guo YX, et al.Summary on the function of collagen[J]. Heilongjiang Agricultural Sciences, 2014(3):150-156. DOI: 10.3969/j.issn.1002-2767.2014.03.045. [34] 游爽. III型胶原蛋白对大鼠阴道萎缩的作用及机制研究[D]. 重庆:重庆医科大学,2020. You S.The function and mechanism of type III collagen on vagina atrophy rats[D]. Chongqing: Chongqing Medical University,2020. [35] 迪丽努尔·吾布力, 刘新莲, 黄修菊, 等. 4种不同方案治疗绝经后萎缩性阴道炎疗效评价[J].国际妇产科学杂志,2019,46(4):387-391. DOI: 10.3969/j.issn.1674-1870.2019.04.006. Dilinuer·wubuli, Liu XL, Huang XJ, et al. The efficacy of four different therapies in postmenopausal atrophic vaginitis[J]. Journal of International Obstetrics and Gynecology,2019,46(4):387-391. DOI: 10.3969/j.issn.1674-1870.2019.04.006. [36] Wang J, Zhang KS, Wang T, et al.Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study[J]. BMC Cancer, 2019,19(1):1219. DOI: 10.1186/s12885-019-6423-5. [37] Westerveld H, Pötter R, Berger D, et al.Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy[J]. Radiother Oncol, 2013,107(1):99-105. DOI: 10.1016/j.radonc.2013.04.009. [38] Westerveld H, de Leeuw A, Kirchheiner K, et al. Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients[J]. Radiother Oncol, 2016,120(3):420-427. DOI: 10.1016/j.radonc.2016.05.002. [39] Chen JH, Bai PG, Zhang XC, et al.Automated intensity modulated radiation therapy treatment planning for cervical cancer based on convolution neural network[J]. Technol Cancer Res Treat, 2020,19:1533033820957002. DOI: 10.1177/1533033820957002. [40] 杨鑫, 何虹, 郭婷. 女性盆腔肿瘤放疗后阴道狭窄影响因素及预防措施的研究进展[J].护理研究,2019,33(22):3918-3921. DOI: 10.12102/j.issn.1009-6493.2019.22.020. Yang X, He H, Guo T.Research progress on factors influencing vaginal stenosis after radiation therapy for female pelvic tumors and prevention methods[J]. Chinese Nursing Research, 2019,33(22):3918-3921. DOI: 10.12102/j.issn.1009-6493.2019.22.020. [41] Brotman RM, He X, Gajer P, et al.Association between cigarette smoking and the vaginal microbiota: a pilot study[J]. BMC Infect Dis, 2014,14:471. DOI: 10.1186/1471-2334-14-471. [42] Corrêa CS, Leite IC, Andrade AP, et al.Sexual function of women surviving cervical cancer[J]. Arch Gynecol Obstet, 2016,293(5):1053-1063. DOI: 10.1007/s00404-015-3857-0. [43] 甄宏楠, 田园, 沈晶, 等. 宫颈癌放疗患者性生活质量分析[J]. 中国医学科学院学报,2019,41(4):501-505. DOI: 10.3881/j.issn.1000-503X.11289. Zhen HN, Tian Y, Shen J, et al. Sexual quality of life in patients undergoing radiotherapy[J]. Acta Acad Med Sin, 2019,41(4):501-505.DOI: 10.3881/j.issn.1000-503X.11289. [44] 黄闻, 张小茹, 张翀旎. 心理干预对宫颈癌放化疗患者负性情绪及生活质量影响的Meta分析[J].西北国防医学杂志,2018,39(11):711-716. DOI: 10.16021/j.cnki.1007-8622.2018.11.003.
2023, Vol. 32 
